Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:October 15, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:October 15, 2021Completed
Condition(s):DeliriumLast Updated:October 31, 2018Terminated
Condition(s):Acute Myeloid Leukemia; AMLLast Updated:June 28, 2012Completed
Condition(s):Acute Myeloid LeukemiaLast Updated:November 19, 2019Recruiting
Condition(s):Cystitis; Erysipelas; PneumoniaLast Updated:March 7, 2024Recruiting
Condition(s):Diarrhea, InfantileLast Updated:November 24, 2023Completed
Condition(s):Acute Myeloid LeukemiaLast Updated:January 25, 2022Unknown status
Condition(s):SepsisLast Updated:June 30, 2021Completed
Condition(s):Geriatric DisorderLast Updated:August 24, 2020Completed
Condition(s):Acute Myeloid LeukemiaLast Updated:June 18, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.